Purity >80% by SDS-PAGE and Coomassie blue staining. MW (theoretical): 23 kDa. The MYCL1/L-Myc Recombinant Protein Antigen from Novus Biologicals is derived from E. coli. The MYCL1/L-Myc Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Size
100 ul
Concentration
n/a
Applications
Antibody Competition
Other Names
BHLHE38, bHLHe38myc-related gene from lung cancer, Class E basic helix-loop-helix protein 38, LMYCl-myc-1 proto-oncogene, MYCL, protein L-Myc-1, v-myc avian myelocytomatosis viral oncogene homolog 1, lung carcinoma derived, v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)